Predicate |
Object |
contentType |
Case Reports|Journal Article |
endingPage |
557 |
issn |
1699-048X 1699-3055 |
issueIdentifier |
8 |
pageRange |
554-557 |
publicationName |
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico |
startingPage |
554 |
bibliographicCitation |
Mendiola C, Vaz MÁ. Is capecitabine a new choice of treatment for lung adenocarcinoma? A case report involving partial response in second line of treatment and hypothesis of the biological basis. Clinical and Translational Oncology. 2009 Aug 29;11(8):554–7. doi: 10.1007/s12094-009-0403-1. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_51049c28960f42d1fc84159d863014f3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_08422f008c1b6e9eae4fc9fd6058bf6b |
date |
2009-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://doi.org/10.1007/s12094-009-0403-1 https://pubmed.ncbi.nlm.nih.gov/19661033 |
isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32427 https://portal.issn.org/resource/ISSN/1699-048X https://portal.issn.org/resource/ISSN/1699-3055 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ https://scigraph.springernature.com/ |
title |
Is capecitabine a new choice of treatment for lung adenocarcinoma? A case report involving partial response in second line of treatment and hypothesis of the biological basis |
discusses |
http://id.nlm.nih.gov/mesh/M0001471 http://id.nlm.nih.gov/mesh/M0008631 http://id.nlm.nih.gov/mesh/M0005997 http://id.nlm.nih.gov/mesh/M0287377 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8366 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1325271ceb6ced42974ded478396cd87 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71296871 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176870 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.4.2.4 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311497 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60750 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46931011 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6650 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3f5453e192e572cbc2bed32097c7aaaf http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44424639 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73265388 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135410875 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60953 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5672 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60780 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13200033 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124 |